Table 1) and WT1 NCN were low at the time of leukemia relapse (Fig. 2c), whereas patient #1, who relapsed with the same AML clone, showed increased WT1 NCN in bone marrow aspirates (Fig. 1c). The gene discussed is WT1; the disease is acute myeloid leukemia.